Approaches to Firearms for Persons With Dementia Discussed

Share this content:
Approaches to Firearms for Persons With Dementia Discussed
Approaches to Firearms for Persons With Dementia Discussed

TUESDAY, May 8, 2018 (HealthDay News) -- Approaches to addressing the potential complications of owning firearms for persons with dementia (PWD) are presented in an article published online May 8 in the Annals of Internal Medicine.

Noting that 7.8 to 11.8 million PWD may live in a home with a firearm by 2050, Marian E. Betz, M.D., M.P.H., from the University of Colorado School of Medicine in Denver, and colleagues reviewed clinical considerations related to owning a gun for PWD.

The authors note that the primary risk for firearm injury for PWD is suicide; firearms are the most common method of suicide among PWD. In addition, PWD access to firearms may place families and caregivers at risk. There is currently no validated screening tool to assess access to firearms among cognitively impaired individuals; furthermore, the most appropriate time and location for screening is not well-established. For patients with minimal cognitive impairment, approaches to firearms could be similar to those related to driving, including proactively discussing firearm access and considering setting a firearm retirement date. If PWD are explicitly identified as unsafe around firearms, guns should be securely locked to prevent unsupervised access, guns should be stored elsewhere, or unwanted firearms should be disposed of permanently.

"We believe that a concerted, cooperative effort making the best use of the data at hand can help prevent injuries and deaths while protecting the dignity and rights of older adults," the authors write.

Abstract/Full Text

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters


More in Home

Social, Communication Delays With False-Negative on M-CHAT

Social, Communication Delays With False-Negative on M-CHAT

Delays for those who pass M-CHAT screening at 18 months but are later diagnosed with ASD

FDA Approves Aimovig to Prevent Migraines

FDA Approves Aimovig to Prevent Migraines

Patients taking Aimovig reported one to two fewer monthly migraine days than those taking pacebo

Risk of Dementia Up for Older Adults With Lowest Wealth

Risk of Dementia Up for Older Adults With ...

Increased risk seen independent of education, index of multiple deprivation, health indicators

is free, fast, and customized just for you!

Already a member?

Sign In Now »